Calls
1
Catherine Owen Adams
CEO, Acadia Pharmaceuticals
Win Rate
100.0%
return
+3.8%
Ticker
Side
Mentions
First Call
Call Price
P&L
Thesis
Theme
Source
Long
Jan 12
$26.59
+3.8%
Acadia is focused on neurological disease and rare disease, where it can address patient communities with few options. She says the company remains committed to this area despite policy changes, is not disrupted by government research funding cuts, and engages with policymakers; it also has strong patient-support programs and received approval for a new formulation in December.
Pharma & Biotech
Showing 1 of 1 calls · sorted by mentions
Choose a mentions count to open ticker posts.
Catherine Owen Adams has 1 trade ideas tracked on Buzzberg across 1 tickers since January 2026. Most covered: ACAD, NEUROSCIENCE AND RARE DISEASE THERAPEUTICS.
Historical call returns are modeled from recorded ideas and stored prices, not actual brokerage portfolio returns. Check the evaluated call set and horizon; past results do not establish future prediction accuracy. Explore our data and methodology
